<DOC>
	<DOCNO>NCT03100071</DOCNO>
	<brief_summary>Cancer patient Central Venous Catheter ( CVC ) Associated Deep Vein Thrombosis ( DVT ) treat Low Molecular Weight Heparin ( LMWH ) apixaban . Study duration 12 week .</brief_summary>
	<brief_title>Central Venous Catheter ( CVC ) Associated Deep Vein Thrombosis ( DVT ) Cancer Patients</brief_title>
	<detailed_description>Cancer patient develop blood clot arm central venous catheter treat standard care blood thin injection low molecular weight heparin 1 week apixaban 5 mg twice daily rest 11 week . Data collect see central venous catheter `` survive '' remain place take clot .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Upper Extremity Deep Vein Thrombosis</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<criteria>1 . Male female &gt; 18 year age . 2 . Symptomatic acute upper limb thrombosis axillary , subclavian internal jugular vein , without pulmonary embolism , associated central venous catheter objectively document compression ultrasonography , venogram Computerized Tomography ( CT ) scan . 3 . Diagnosis active malignancy , define patient either receive active treatment , metastatic disease diagnose within past two year . 4 . Willing provide write informed consent . 1 . Presence dialysis catheter 2 . Active bleeding high risk major bleed 3 . Platelet Count &lt; 75 x 109/L 4 . Creatinine Clearance &lt; 30 mL/min 5 . Currently anticoagulant therapeutic intent another indication 6 . Pulmonary embolism accompany hemodynamic instability oxygen requirement 7 . Inability infuse catheter trial intraluminal thrombolytic therapy ( 2 mg tPA ) . 8 . Patients Acute Myeloid Leukemia ( AML ) , Acute Lymphoblastic Leukemia ( ALL ) multiple myeloma bone marrow stem cell transplant plan within next 3 month 9 . Treatment current episode &gt; 7 day acceptable anticoagulant therapy 10 . Concomitant use pglucoprotein Cytochrome P450 3A4 ( CYP3A4 ) inhibitor ( example azole antifungal ketoconazole ) inducer ( example rifampicin , antiepileptic ) 11 . Recent coronary artery stent require dual antiplatelet therapy ( example acetylsalicylic acid [ ASA ] Plavix ) 12 . If female childbearing potential : pregnancy and/or breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>